ACARIZAX Lyophilisat oral 12 SQ-HDM 90 pce
7680658230023
CH-65823
V01AA03
07.13.3.
Reimbursement limitations:
071330
Prise en charge seulement après exploration allergologique.
1 / 3
google
Details
- Product number
- 6582301
- CPT
- -
- Packaging group
- 90
- Unit
- Einzeldose(n)
- Composition
- Praeparatio cryodesiccata: acari allergeni extractum 12 U. ut acari allergeni extractum (Dermatophagoides pteronyssinus) et acari allergeni extractum (Dermatophagoides farinae), gelatina, mannitolum 12.7 mg, natrii hydroxidum, pro dosi corresp. natrium 0.14 mg.
Articles (1)
Acarizax, Lyophilisat zum Einnehmen
Lyophilisat
90
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
12.0 U | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
12.7 MG | Substance | HBESI |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
0.14 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 268.65
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/11/2016
Authorization holder
ALK-Abelló AG
8304 Wallisellen
Authorization information
- Swissmedic authorization number
- 65823
- Drug name
- Acarizax, Lyophilisat zur sublingualen Anwendung
- Galenic form
- LYSUV
- ATC Code
- V01AA03
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 24/08/2016
- Authorization expiration date
- 31/12/9999
- IT number
- 07.13.3.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ACARIZAX Lyophilisat oral 12 SQ-HDM 90 pce
- Description (DE)
- ACARIZAX Lyophilisat oral 12 SQ-HDM 90 Stk
- Market launch
- 24/08/2016
- Narcotic (BTM)
- No